Information from legal claims relating to other children treated at Alder Hey revealed the same approach to treatment. For one patient a note detailed that NHS concentrate should have been preferred to commercial from about mid-1983 but supplies were inadequate to adhere entirely to this counsel of perfection. Read more about Information from legal claims relating to other children treated at Alder Hey revealed the same approach to treatment. For one patient a note detailed that NHS concentrate should have been preferred to commercial from about mid-1983 but supplies were inadequate to adhere entirely to this counsel of perfection.
Dr Savidge considered Dr Martin's treatment for Stephen "at these times when heat treated concentrates were commercially available was negligent." Read more about Dr Savidge considered Dr Martin's treatment for Stephen "at these times when heat treated concentrates were commercially available was negligent."
Dr Savidge assessed the treatment of infants and children throughout the late 1970s and early 1980s stating "The lack of consideration and disregard of the then current therapeutic recommendations for the treatment of children under the age of 4 years regarding the use of cryoprecipitate in this case was negligent...The overwhelming use of commercial U.S. concentrates in preference to cryoprecipitate or NHS factor VIII is remarkable," Read more about Dr Savidge assessed the treatment of infants and children throughout the late 1970s and early 1980s stating "The lack of consideration and disregard of the then current therapeutic recommendations for the treatment of children under the age of 4 years regarding the use of cryoprecipitate in this case was negligent...The overwhelming use of commercial U.S. concentrates in preference to cryoprecipitate or NHS factor VIII is remarkable,"
Dr Savidge continues in his report stating Stephen twice received unheated US concentrates in early 1985. Read more about Dr Savidge continues in his report stating Stephen twice received unheated US concentrates in early 1985.
Dr Savidge's report in 1992 revealed that Stephen, at the age of two years old, was treated with US commercial concentrates on 32 occasions in the course of 1982. He was treated with US commercial concentrates repeatedly again in 1983 and 1984, including as late as December 1984. Read more about Dr Savidge's report in 1992 revealed that Stephen, at the age of two years old, was treated with US commercial concentrates on 32 occasions in the course of 1982. He was treated with US commercial concentrates repeatedly again in 1983 and 1984, including as late as December 1984.
In 1986 Alder Hey treated its Haemophilia A patients only with factor concentrate. Read more about In 1986 Alder Hey treated its Haemophilia A patients only with factor concentrate.
In 1984 Alder Hey treated its Haemophilia A patients only with concentrates, both commercial and NHS. Read more about In 1984 Alder Hey treated its Haemophilia A patients only with concentrates, both commercial and NHS.
Annual Returns for Alder Hey Children's Hospital for 1983 recorded the almost exclusive use of concentrate, which was mostly Factorate. Read more about Annual Returns for Alder Hey Children's Hospital for 1983 recorded the almost exclusive use of concentrate, which was mostly Factorate.
Annual Returns for Alder Hey Children's Hospital 1982 recorded Alder Hey used almost exclusively concentrate, most of which was commercial. Read more about Annual Returns for Alder Hey Children's Hospital 1982 recorded Alder Hey used almost exclusively concentrate, most of which was commercial.
Annual Returns for Alder Hey Children's Hospital 1981 recorded Alder Hey treated its haemophilia patients almost exclusively with concentrate (both NHS and Factorate). Read more about Annual Returns for Alder Hey Children's Hospital 1981 recorded Alder Hey treated its haemophilia patients almost exclusively with concentrate (both NHS and Factorate).